Citation Impact
Citing Papers
Lack of prognostic relevance of alterations in the epidermal growth factor receptor—transforming growth factor-α pathway in human astrocytic gliomas
1996
Constitutive Activation of Phosphatidylinositol 3-Kinase by a Naturally Occurring Mutant Epidermal Growth Factor Receptor
1998
Untangling the ErbB signalling network
2001 Standout
Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: A Multisite Randomized Controlled Trial
2007 Standout
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
Investigation of intraoperative brain deformation using a 1.5-T interventional MR system: preliminary results
1998
Mutual-information-based registration of medical images: a survey
2003 Standout
The RB and p53 pathways in cancer
2002 Standout
The WHO Classification of Tumors of the Nervous System
2002 Standout
HIF-1: Using Two Hands to Flip the Angiogenic Switch
2000 StandoutNobel
Overexpression of the EGF Receptor and p53 Mutations are Mutually Exclusive in the Evolution of Primary and Secondary Glioblastomas
1996
Mammalian phosphoinositide kinases and phosphatases
2009 StandoutNobel
Genetics and new approaches to cancer therapy
2002
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
2006 Standout
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Intravenously-injected gold nanoparticles (AuNPs) access intracerebral F98 rat gliomas better than AuNPs infused directly into the tumor site by convection enhanced delivery
2018
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
2002 Standout
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
The mini-driver model of polygenic cancer evolution
2015 StandoutNobel
Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells
2008 Standout
Epidermal growth factor receptor: mechanisms of activation and signalling
2003
Constitutive activation of Stat3α in brain tumors: localization to tumor endothelial cells and activation by the endothelial tyrosine kinase receptor (VEGFR-2)
2002
EGF–ERBB signalling: towards the systems level
2006 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Targeting the phosphoinositide 3-kinase pathway in cancer
2009 Standout
Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease
2001 StandoutNobel
Progress in research on gold nanoparticles in cancer management
2019 Standout
The Molecular and Genetic Basis of Neurological Tumours
2002
The navigation of transcranial magnetic stimulation
2001
p21 in cancer: intricate networks and multiple activities
2009 Standout
Vascular endothelial growth factor in eye disease
2008 Standout
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Targeting RAS signalling pathways in cancer therapy
2003 Standout
mTOR: from growth signal integration to cancer, diabetes and ageing
2010 Standout
The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic target
1998
The Enhanced Tumorigenic Activity of a Mutant Epidermal Growth Factor Receptor Common in Human Cancers Is Mediated by Threshold Levels of Constitutive Tyrosine Phosphorylation and Unattenuated Signaling
1997
Malignant Gliomas in Adults
2008 Standout
Monolayer versus aggregate balance in survival process for EGF‐induced apoptosis in A431 carcinoma cells: Implication of ROS‐P38 MAPK‐integrin α2β1 pathway
2004
Pediatric High-Grade Astrocytomas Show Chromosomal Imbalances Distinct from Adult Cases
2001
Glioblastoma: pathology, molecular mechanisms and markers
2015
EGF mutant receptor vIII as a molecular target in cancer therapy.
2001
Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice
2000
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
Death and anti-death: tumour resistance to apoptosis
2002 Standout
Human glioblastoma xenografts overexpressing a tumor-specific mutant epidermal growth factor receptor sensitized to cisplatin by the AG1478 tyrosine kinase inhibitor
2001
Spontaneous Spinal Cerebrospinal Fluid Leaks and Intracranial Hypotension
2006 Standout
Primary brain tumours in adults
2012 Standout
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
2009 Standout
Identification of human brain tumour initiating cells
2004 StandoutNature
Herniation of the spinal cord
1995
A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice
1998 Nobel
Epidermal growth factor receptor (EGFR) signaling in cancer
2005 Standout
Mutations in SUFU predispose to medulloblastoma
2002 Standout
A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma
2006
Brain Tumors
2001 Standout
Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma
2010
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
2004 Standout
The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
2008 StandoutNobel
Tumor spectrum in ARF-deficient mice.
1999
Management of glioblastoma: State of the art and future directions
2020 Standout
Identification of a cancer stem cell in human brain tumors.
2003 Standout
Velvet, a Dominant Egfr Mutation That Causes Wavy Hair and Defective Eyelid Development in Mice
2004 StandoutNobel
A Mouse Model for Glioma: Biology, Pathology, and Therapeutic Opportunities
2000
Patterns of epidermal growth factor receptor amplification in malignant gliomas.
1996
Analysis of oncogene and tumor suppressor gene alterations in pediatric malignant astrocytomas reveals reduced survival for patients with PTEN mutations.
1999
Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-X L and caspase-3-like proteases
1998
Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas.
2001
The selectivity of protein kinase inhibitors: a further update
2007 Standout
Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects
2005 Standout
HIF-1 and human disease: one highly involved factor
2000 StandoutNobel
Cancerous stem cells can arise from pediatric brain tumors
2003 Standout
A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.
1994
Epidemiologic and Molecular Prognostic Review of Glioblastoma
2014 Standout
Works of Fritz Albert being referenced
Einfluß des Hirnödems auf das Rezidivwachstum maligner Gliome
1998
Amplification of the epidermal‐growth‐factor‐receptor gene correlates with different growth behaviour in human glioblastoma
1994
Neuronavigation--first experiences with three different commercially available systems.
1998
Intraoperative magnetic resonance imaging to update interactive navigation in neurosurgery: Method and preliminary experience
1997
Hernia of the spinal cord
1991